Swiss aging-biotech (formerly Rejuveron) building a portfolio of therapeutics targeting the hallmarks of aging.
Combination gene therapies targeting the biology of aging and age-related disease in companion animals and humans.
Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.
Already subscribed? Sign in →